‘Overcharging’ claims give false impression

26 June 2017 - Guild condemns PBS price fixing suggestion as article accuses pharmacies of overcharging. ...

Read more →

Has the interim report considered long term supply chain impacts?

23 June 2017 - Medicines Australia welcomes the release of the Interim Report of Pharmacy Review but has concerns about ...

Read more →

Chemists have been overcharging customers for medicines a government review finds

24 June 2017 - The price of the same PBS medicine can vary by up to 200% from shop to ...

Read more →

Consumer voice for community pharmacy

22 June 2017 - Consumers would win an important place in future negotiations about government payments to pharmacy owners and ...

Read more →

Price disclosure 2017 October cycle outcomes summary

16 June 2017 - The summary of price disclosure price reductions for the 2017 October Cycle (Third Remove Originator cycle) has ...

Read more →

ACCC 'more aggressive' towards private health insurers

31 May 2017 - The corporate watchdog has made an example of NIB as part of a wider review of ...

Read more →

Laws introduced to 'guarantee' Medicare

1 June 2017 - The Turnbull government insists a new multi-billion dollar fund will guarantee the future of Medicare, amid ...

Read more →

$55,000 spent but hospital funding reform ‘will never be policy’

30 May 2017 - A proposal to pay hospitals in a similar way to Medicare’s funding of GPs has been ...

Read more →

ACCC takes health fund NIB to court over concealing changes to its MediGap Scheme

30 May 2017 - The consumer watchdog has taken health fund NIB to court, accusing it of concealing changes to ...

Read more →

Why you could have to pay $1 more for medicine

13 May 2017 - Health Minister Greg Hunt has changed his script - and the change is about to hit ...

Read more →

Another small victory for Australian Government in its pursuit of damages for PBS over-payments during interlocutory injunction period

4 May 2017 - The Australian Government has had another small victory in the most recent interlocutory decision in the clopidogrel ...

Read more →

‘Basic Bronze’ proposal to cut health insurance premiums

1 May 2017 - Health funds would be compelled to offer a standard, low-cost ­insurance policy under a proposal being ...

Read more →

The multi-billion-dollar subsidy for private health insurance isn’t worth it

27 April 2017 - Almost 20 years after the 30% subsidy for private health insurance was introduced, premiums continue to ...

Read more →

Brenzys lists on the Australian PBS and Pfizer denied discovery of documents to establish grounds for patent infringement

4 April 2017 - As of 1 April 2017, Samsung Bioepis' Brenzys, a biosimilar to Pfizer's Enbrel (etanercept), will join ...

Read more →

$30m damages for infringement of Bayer’s Australian Yasmin patent - a “small” jurisdiction with big benefits

29 March 2017 - In a recent landmark Australian Federal Court decision, Bayer v Generic Health FCA 250, Bayer was awarded ...

Read more →